AC Immune to Participate in Upcoming Virtual Investor Conferences in September
AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in the following upcoming virtual investor conferences: